| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |